Analyst Ratings for Evolent Health (EVH)
EVH Rating Summary
EVH Price Target Summary
- Highest: $52.00 (JPMorgan)
- Lowest: $34.00 (Truist Securities)
- Average: $43.44
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$43.44 (+53.4%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$43.44 (+53.4%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/22/2024 | Citi | Daniel Grosslight | New Coverage | Buy (N/A) |
40.00 (N/A) |
29.51 (28.32) |
-4.03% | Details |
| 1/3/2024 | Barclays | N/A | New Coverage | Overweight (N/A) |
39.00 (N/A) |
33.03 (28.32) |
-14.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
